Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Dec 21;12(12):CD013217.
doi: 10.1002/14651858.CD013217.pub2.

Non-pharmacological care for opioid withdrawal in newborns

Adrienne Pahl  1 , Leslie Young  2 , Madge E Buus-Frank  3   4 , Lenora Marcellus  5 , Roger Soll  2
Affiliations
Meta-Analysis

Non-pharmacological care for opioid withdrawal in newborns

Adrienne Pahl et al. Cochrane Database Syst Rev. .

Abstract

Background: The prevalence of substance use, both prescribed and non-prescribed, is increasing in many areas of the world. Substance use by women of childbearing age contributes to increasing rates of neonatal abstinence syndrome (NAS). Neonatal opioid withdrawal syndrome (NOWS) is a newer term describing the subset of NAS related to opioid exposure. Non-pharmacological care is the first-line treatment for substance withdrawal in newborns. Despite the widespread use of non-pharmacological care to mitigate symptoms of NAS, there is not an established definition of, and standard for, non-pharmacological care practices in this population. Evaluation of safety and efficacy of non-pharmacological practices could provide clear guidance for clinical practice.

Objectives: To evaluate the safety and efficacy of non-pharmacological treatment of infants at risk for, or having symptoms consistent with, opioid withdrawal on the length of hospitalization and use of pharmacological treatment for symptom management. Comparison 1: in infants at risk for, or having early symptoms consistent with, opioid withdrawal, does non-pharmacological treatment reduce the length of hospitalization and use of pharmacological treatment? Comparison 2: in infants receiving pharmacological treatment for symptoms consistent with opioid withdrawal, does concurrent non-pharmacological treatment reduce duration of pharmacological treatment, maximum and cumulative doses of opioid medication, and length of hospitalization?

Search methods: We used the standard search strategy of Cochrane Neonatal to search CENTRAL (2019, Issue 10); Ovid MEDLINE; and CINAHL on 11 October 2019. We also searched clinical trials databases and the reference lists of retrieved articles for randomized controlled trials (RCTs), quasi-RCTs, and cluster trials.

Selection criteria: We included trials comparing single or bundled non-pharmacological interventions to no non-pharmacological treatment or different single or bundled non-pharmacological interventions. We assessed non-pharmacological interventions independently and in combination based on sufficient similarity in population, intervention, and comparison groups studied. We categorized non-pharmacological interventions as: modifying environmental stimulation, feeding practices, and support of the mother-infant dyad. We presented non-randomized studies identified in the search process narratively.

Data collection and analysis: We used standard methodological procedures expected by Cochrane. We used the GRADE approach to assess the certainty of evidence. Primary outcomes in infants at risk for, or having early symptoms consistent with, opioid withdrawal included length of hospitalization and pharmacological treatment with one or more doses of opioid or sedative medication. Primary outcomes in infants receiving opioid treatment for symptoms consistent with opioid withdrawal included length of hospitalization, length of pharmacological treatment with opioid or sedative medication, and maximum and cumulative doses of opioid medication.

Main results: We identified six RCTs (353 infants) in which infants at risk for, or having symptoms consistent with, opioid withdrawal participated between 1975 and 2018. We identified no RCTs in which infants receiving opioid treatment for symptoms consistent with opioid withdrawal participated. The certainty of evidence for all outcomes was very low to low. We also identified and excluded 34 non-randomized studies published between 2005 and 2018, including 29 in which infants at risk for, or having symptoms consistent with, opioid withdrawal participated and five in which infants receiving opioid treatment for symptoms consistent with opioid withdrawal participated. We identified seven preregistered interventional clinical trials that may qualify for inclusion at review update when complete. Of the six RCTs, four studies assessed modifying environmental stimulation in the form of a mechanical rocking bed, prone positioning, non-oscillating waterbed, or a low-stimulation nursery; one study assessed feeding practices (comparing 24 kcal/oz to 20 kcal/oz formula); and one study assessed support of the maternal-infant dyad (tailored breastfeeding support). There was no evidence of a difference in length of hospitalization in the one study that assessed modifying environmental stimulation (mean difference [MD) -1 day, 95% confidence interval [CI) -2.82 to 0.82; 30 infants; very low-certainty evidence) and the one study of support of the maternal-infant dyad (MD -8.9 days, 95% CI -19.84 to 2.04; 14 infants; very low-certainty evidence). No studies of feeding practices evaluated the length of hospitalization. There was no evidence of a difference in use of pharmacological treatment in three studies of modifying environmental stimulation (typical risk ratio [RR) 1.00, 95% CI 0.86 to 1.16; 92 infants; low-certainty evidence), one study of feeding practices (RR 0.92, 95% CI 0.63 to 1.33; 49 infants; very low-certainty evidence), and one study of support of the maternal-infant dyad (RR 0.50, 95% CI 0.13 to 1.90; 14 infants; very low-certainty evidence). Reported secondary outcomes included neonatal intensive care unit (NICU) admission, days to regain birth weight, and weight nadir. One study of support of the maternal-infant dyad reported NICU admission (RR 0.50, 95% CI 0.13 to 1.90; 14 infants; very low-certainty evidence). One study of feeding practices reported days to regain birth weight (MD 1.10 days, 95% CI 2.76 to 0.56; 46 infants; very low-certainty evidence). One study that assessed modifying environmental stimulation reported weight nadir (MD -0.28, 95% CI -1.15 to 0.59; 194 infants; very low-certainty evidence) and one study of feeding practices reported weight nadir (MD -0.8, 95% CI -2.24 to 0.64; 46 infants; very low-certainty evidence).

Authors' conclusions: We are uncertain whether non-pharmacological care for opioid withdrawal in newborns affects important clinical outcomes including length of hospitalization and use of pharmacological treatment based on the six included studies. The outcomes identified for this review were of very low- to low-certainty evidence. Combined analysis was limited by heterogeneity in study design and intervention definitions as well as the number of studies. Many prespecified outcomes were not reported. Although caregivers are encouraged by experts to optimize non-pharmacological care for opioid withdrawal in newborns prior to initiating pharmacological care, we do not have sufficient evidence to inform specific clinical practices. Larger well-designed studies are needed to determine the effect of non-pharmacological care for opioid withdrawal in newborns.

Trial registration: ClinicalTrials.gov NCT02768844 NCT02801331 NCT03097484 NCT03533985 NCT03549936 NCT03987165.

PubMed Disclaimer

Conflict of interest statement

AP: none.

LY: none.

MEBF: none.

LM has worked with Vermont Oxford Network since 2012 and received payments for lectures.

RS is the Co‐ordinating Editor of Cochrane Neonatal, President and Director of Clinical Trials of the Vermont Oxford Network, and a professor at the University of Vermont. Previously he has acted as a consultant and invited speaker for several of the pharmaceutical companies that manufacture surfactant preparations (Abbott Laboratories, Ross Laboratories, Chiesi Pharmaceuticals, Dey Laboratories, Burroughs Wellcome). He has done no paid consulting work since 2010.

Figures

1
1
Study flow diagram.
2
2
Risk of bias summary: review authors' judgments about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 1: Length of hospitalization (days)
1.2
1.2. Analysis
Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 2: Pharmacological treatment with ≥ 1 doses of opioid or sedative medication
1.3
1.3. Analysis
Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 3: Peak neonatal abstinence syndrome (NAS) score in first 72 hours of life
1.4
1.4. Analysis
Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 4: Neonatal intensive care unit admission
1.5
1.5. Analysis
Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 5: Days to regain birth weight
1.6
1.6. Analysis
Comparison 1: Infants at risk for, or having early symptoms consistent with, opioid withdrawal, Outcome 6: Weight nadir (% weight loss)
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD013217

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Bogen 2018 {published data only}
    1. Bogen DL, Hanusa BH, Baker R, Medoff-Cooper B, Cohlan B. Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hospital Pediatrics 2018;8(1):7-14. [DOI: 10.1542/hpeds.2017-0114] [PMID: ] - DOI - PMC - PubMed
D'Apolito 1999 {published data only}
    1. D'Apolito K. Comparison of a rocking bed and standard bed for decreasing withdrawal symptoms in drug-exposed infants. MCN. The American Journal of Maternal Child Nursing 1999;24(3):138-44. [DOI: 10.1097/00005721-199905000-00007] [PMID: ] - DOI - PubMed
MacVicar 2018 {published data only}
    1. MacVicar S, Humphrey T, Forbes-McKay KE. Breastfeeding and the substance-exposed mother and baby. Birth 2018;45(4):450-8. [DOI: 10.1111/birt.12338] [PMID: ] - DOI - PubMed
Maichuk 1999 {published data only}
    1. Maichuk GT, Zahorodny W, Marshall R. Use of positioning to reduce the severity of neonatal narcotic withdrawal syndrome. Journal of Perinatology 1999;19(7):510-3. [DOI: 10.1038/sj.jp.7200260] [PMID: ] - DOI - PubMed
Oro 1988 {published data only}
    1. Oro AS, Dixon SD. Waterbed care of narcotic-exposed neonates. A useful adjunct to supportive care. American Journal of Diseases of Children 1988;142(2):186-8. [DOI: 10.1001/archpedi.1988.02150020088036] [PMID: ] - DOI - PubMed
Ostrea 1975 {published data only}
    1. Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases 1975;2(1-2):187-99. [PMID: ] - PubMed

References to studies excluded from this review

Abdel‐Latif 2006 {published data only}
    1. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006;117(6):e1163-9. [DOI: ] [PMID: ] - PubMed
Abrahams 2007 {published data only}
    1. Abrahams RR, Kelly SA, Payne S, Thiessen PN, Mackintosh J, Janssen PA. Rooming-in compared with standard care for newborns of mothers using methadone or heroin. Canadian Family Physician Médecin de Famille Canadien 2007;53(10):1722-30. [DOI: 53/10/1722 [pii]] [PMID: ] - PMC - PubMed
Abrahams 2010 {published data only}
    1. Abrahams RR, Mackay-Dunn MH, Nevmerjitskaia V, Macrae GS, Payne SP, Hodgson ZG. An evaluation of rooming-in among substance-exposed newborns in British Columbia. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC] 2010;32(9):866-71. [DOI: ] [PMID: ] - PubMed
Arlettaz 2005 {published data only}
    1. Arlettaz R, Kashiwagi M, Das-Kundu S, Fauchère JC, Lang A, Bucher HU. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstetricia et Gynecologica Scandinavica 2005;84(2):145-50. [DOI: ] [PMID: ] - PubMed
Crook 2017 {published data only}
    1. Crook K, Brandon D. Prenatal breastfeeding education: impact on infants with neonatal abstinence syndrome. Advances in Neonatal Care 2017;17(4):299-305. [DOI: 10.1097/ANC.0000000000000392] [PMID: ] - DOI - PubMed
Dryden 2009 {published data only}
    1. Dryden C, Young D, Campbell N, Mactier H. Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Archives of Disease in Childhood. Fetal and Neonatal Edition 2012;97(3):F214-6. [DOI: ] [PMID: ] - PubMed
    1. Dryden C, Young D, Hepburn M, Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009;116(5):665-71. [DOI: 10.1111/j.1471-0528.2008.02073.x] [PMID: ] - DOI - PubMed
Grossman 2017 {published data only}
    1. Grossman MR, Berkwitt AK, Osborn RR, Xu Y, Esserman D, Shapiro E, et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics 2017;139(6):e20163360. [DOI: 10.1542/peds.2016-3360] [PMID: ] - DOI - PMC - PubMed
Hodgson 2012 {published data only}
    1. Hodgson ZG, Abrahams RR. A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC] 2012;34(5):475-81. [DOI: 10.1016/s1701-2163(16)35245-8] [PMID: ] - DOI - PubMed
Holmes 2016 {published data only}
    1. Holmes AV, Atwood EC, Whalen B, Beliveau J, Jarvis JD, Matulis JC, et al. Rooming-in to treat neonatal abstinence syndrome: improved family-centered care at lower cost. Pediatrics 2016;137(6):e1-e9. [DOI: ] [PMID: ] - PubMed
Howard 2017 {published data only}
    1. Howard MB, Schiff DM, Penwill N, Si W, Rai A, Wolfgang T, et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hospital Pediatrics 2017;7(2):62-9. [DOI: 10.1542/hpeds.2016-0147] [PMID: ] - DOI - PubMed
Hünseler 2013 {published data only}
    1. Hünseler C, Brückle M, Roth B, Kribs A. Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience [Neonataler opiatentzug und rooming-in: retrospektive analyse der erfahrungen eines zentrums]. Klinische Pädiatrie 2013;225(5):247-51. [DOI: ] [PMID: ] - PubMed
Isemann 2011 {published data only}
    1. Isemann B, Meinzen-Derr J, Akinbi H. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology 2011;31(1):25-9. [DOI: ] [PMID: ] - PubMed
Jansson 2008 {published data only}
    1. Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM, et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics 2008;121(1):106-14. [DOI: ] [PMID: ] - PubMed
Kirchner 2014 {published data only}
    1. Kirchner L, Graf-Rohrmeister K, Klebermass-Schrehof K, Weninger M, Jagsch R, Metz V, et al. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial [Neonatales Abstinenzsyndrom bei europäischen und nordamerikani-schen Neugeborenen: Unterschiede im klinischen Verlauf an Hand vonDaten einer prospektiven randomisierten Studie]. Klinische Padiatrie 2014;226(5):274-80. [DOI: 10.1055/s-0034-1372586] [PMID: ] - DOI - PubMed
Liu 2015 {published data only}
    1. Liu A, Juarez J, Nair A, Nanan R. Feeding modalities and the onset of the neonatal abstinence syndrome. Frontiers in Pediatrics 2015;3:14. [DOI: ] [PMID: ] - PMC - PubMed
Loudin 2017 {published data only}
    1. Loudin S, Werthammer J, Prunty L, Murray S, Shapiro JI, Davies TH. A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic. Journal of Perinatology 2017;37(10):1108-11. [DOI: ] [PMID: ] - PMC - PubMed
McKnight 2016 {published data only}
    1. McKnight S, Coo H, Davies G, Holmes B, Newman A, Newton L, et al. Rooming-in for infants at risk of neonatal abstinence syndrome. American Journal of Perinatology 2016;33(5):495-501. [DOI: ] [PMID: ] - PubMed
    1. Newman A, Davies GA, Dow K, Holmes B, Macdonald J, McKnight S, et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien 2015;61(12):e555-61. [PMID: ] - PMC - PubMed
McQueen 2011 {published data only}
    1. McQueen KA, Murphy-Oikonen J, Gerlach K, Montelpare W. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Advances in Neonatal Care 2011;11(4):282-90. [DOI: ] [PMID: ] - PubMed
Metz 2011 {published data only}
    1. Metz V, Jagsch R, Ebner N, Wurzl J, Pribasnig A, Aschauer C, et al. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women. Human Psychopharmacology 2011;26(6):412-21. [DOI: ] [PMID: ] - PMC - PubMed
Metz 2015 {published data only}
    1. Metz VE, Comer SD, Pribasnig A, Wuerzl J, Fischer G. Observational study in an outpatient clinic specializing in treating opioid dependent pregnant women: neonatal abstinence syndrome in infants exposed to methadone-, buprenorphine- and slow-release oral morphine. Heroin Addiction and Related Clinical Problems 2015;17(1):5-16.
Miles 2007 {published data only}
    1. Miles J, Sugumar K, Macrory F, Sims DG, D'Souza SW. Methadone-exposed newborn infants: outcome after alterations to a service for mothers and infants. Child Care Health and Development 2007;33(2):206-12. [DOI: ] [PMID: ] - PubMed
O'Connor 2013 {published data only}
    1. O'Connor AB, Collett A, Alto WA, O'Brien LM. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. Journal of Midwifery and Women's Health 2013;58(4):383-8. [DOI: ] [PMID: ] - PubMed
Ordean 2015 {published data only}
    1. Ordean A, Kahan M, Graves L, Abrahams R, Kim T. Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a Canadian multisite cohort study. Journal d'Obstetrique et Gynecologie du Canada : JOGC [Journal of Obstetrics and Gynaecology Canada : JOGC] 2015;37(3):252-7. [DOI: ] [PMID: ] - PubMed
Patrick 2016 {published data only}
    1. Patrick SW, Schumacher RE, Horbar JD, Buus-Frank M, Edwards E, Morrow K, et al. Improving care for neonatal abstinence syndrome. Pediatrics 2016;137(5):e20153835. [DOI: 10.1542/peds.2015-3835] [PMID: ] - DOI - PMC - PubMed
Pritham 2012 {published data only}
    1. Pritham UA, Paul JA, Hayes MJ. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing 2012;41(2):180-90. [DOI: 10.1111/j.1552-6909.2011.01330.x] [PMID: ] - DOI - PMC - PubMed
Radmacher 2017 {published data only}
    1. Radmacher P, Alexander C, Devlin L. Donor human milk may decrease severe gastrointestinal distress in infants with neonatal abstinence syndrome. Journal of Pregnancy and Neonatal Medicine 2017;1(1):11-5. [DOI: 10.35841/neonatal-medicine.1.1.11-15] - DOI
Radziewicz 2018 {published data only}
    1. Radziewicz RM, Wright-Esber S, Zupancic J, Gargiulo D, Woodall P. Safety of reiki therapy for newborns at risk for neonatal abstinence syndrome. Holistic Nursing Practice 2018;32(2):63-70. [DOI: 10.1097/HNP.0000000000000251] [PMID: ] - DOI - PMC - PubMed
Saiki 2010 {published data only}
    1. Saiki T, Lee S, Hannam S, Greenough A. Neonatal abstinence syndrome-postnatal ward versus neonatal unit management. European Journal of Pediatrics 2010;169(1):95-8. [DOI: ] [PMID: ] - PubMed
Short 2016 {published data only}
    1. Short VL, Gannon M, Abatemarco DJ. The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeeding Medicine 2016;11(7):343-9. [DOI: ] [PMID: ] - PubMed
Summey 2018 {published data only}
    1. Summey J, Chen L, Mayo R, Charron E, Hudson JA, Sherrill WW, et al. Early treatment innovation for opioid-dependent newborns: a retrospective comparison of outcomes, utilization, quality, and safety, 2006–2014. Joint Commission Journal on Quality and Patient Safety / Joint Commission Resources 2018;44(6):312-20. [DOI: ] [PMID: ] - PubMed
Wachman 2013 {published data only}
    1. Wachman EM, Hayes MJ, Brown MS, Paul J, Harvey-Wilkes K, Terrin N, et al. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome. JAMA 2013;309(17):1821-7. [DOI: ] - PMC - PubMed
Wachman 2018 {published data only}
    1. Wachman EM, Grossman M, Schiff DM, Philipp B, Minear S, Hutton E, et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology 2018;38(8):1114-22. [DOI: ] [PMID: ] - PubMed
Welle‐Strand 2013 {published data only}
    1. Welle-Strand GK, Skurtveit S, Jansson LM, Bakstad B, Bjarko L, Ravndal E. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatrica 2013;102(11):1060-6. [DOI: ] [PMID: 23909865] - PubMed
Zuzarte 2017 {published data only}
    1. Zuzarte I, Indic P, Barton B, Paydarfar D, Bednarek F, Bloch-Salisbury E. Vibrotactile stimulation: a nonpharmacological intervention for opioid exposed newborns. PloS One 2017;12(4):e0175981. [DOI: ] [PMID: ] - PMC - PubMed

References to ongoing studies

NCT02768844 {published data only}
    1. NCT02768844. Physiology and therapeutic management of neonatal abstinence syndrome. clinicaltrials.gov/show/NCT02768844 (first received 11 May 2016).
NCT02801331 {published data only}
    1. NCT02801331. Efficacy and outcomes of a non-pharmacological intervention for neonatal abstinence syndrome. clinicaltrials.gov/show/NCT02801331 (first received 15 June 2016).
NCT03097484 {published data only}
    1. NCT03097484. The effect of aromatherapy on neonatal abstinence syndrome and salivary cortisol levels. clinicaltrials.gov/show/NCT03097484 (first received 31 March 2017).
NCT03113656 {published data only}
    1. NCT03113656. Weighted blankets with infants with NAS. clinicaltrials.gov/show/NCT03113656 (first received 13 April 2017).
NCT03533985 {published data only}
    1. NCT03533985. Effect of music therapy on Infants with Neonatal Abstinence Syndrome. clinicaltrials.gov/show/NCT03533985 (first received 23 May 2018).
NCT03549936 {published data only}
    1. NCT03549936. Role of low lactose infant formula in the management of neonatal abstinence syndrome. clinicaltrials.gov/show/NCT03549936 (first received 8 June 2018).
NCT03987165 {published data only}
    1. NCT03987165. The effect of music therapy on newborns. clinicaltrials.gov/show/NCT03987165 (first received 14 June 2019).

Additional references

Arditi 2006
    1. Arditi H, Feldman R, Eidelman A. Effects of human contact and vagal regulation on pain reactivity and visual attention in newborns. Developmental Psychobiology 2006;48(7):561-73. [DOI: 10.1002/dev.20150] [PMID: ] - DOI - PubMed
Bayley 1993
    1. Bayley N. Bayley Scales of Infant Development-II. San Antonio (TX): Psychological Corporation, 1993.
Bembich 2018
    1. Bembich S, Cont G, Causin E, Paviotti G, Marzari P, Demarini S. Infant analgesia with a combination of breast milk, glucose, or maternal holding. Pediatrics 2018;142(3):e20173416. [DOI: 10.1542/peds.2017-3416] [PMID: ] - DOI - PubMed
Bogen 2017
    1. Bogen D, Whalen B, Kair L, Vining M, King B. Wide variation found in care of opioid-exposed newborns. Academic Pediatrics 2017;17(4):374-80. [DOI: 10.1016/j.acap.2016.10.003] [PMID: ] - DOI - PMC - PubMed
Bogen 2019
    1. Bogen DL, Whalen BL. Breastmilk feeding for mothers and infants with opioid exposure: What is best? Seminars in Fetal & Neonatal Medicine 2019;24(2):95-104. [DOI: 10.1016/j.siny.2019.01.001] - DOI - PubMed
Brockington 2006
    1. Brockington I, Fraser C, Wilson D. The Postpartum Bonding Questionnaire: a validation. Archives of Women's Mental Health 2006;9(5):233-42. [DOI: 10.1007/s00737-006-0132-1] [PMID: ] - DOI - PubMed
Brogly 2014
    1. Brogly S, Saia K, Walley A, Du H, Sebastiani P. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. American Journal of Epidemiology 2014;180(7):673-86. [DOI: 10.1093/aje/kwu190] [PMID: ] - DOI - PubMed
Burns 2007
    1. Burns L, Mattick RP. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome. Drug and Alcohol Review 2007;26(5):487-92. [DOI: 10.1080/09595230701494416] [PMID: ] - DOI - PubMed
Carbajal 2003
    1. Carbajal R, Veerapen S, Couderc S, Jugie M, Ville Y. Analgesic effect of breast feeding in term neonates: randomised controlled trial. BMJ (Clinical Research Ed.) 2003;326(7379):13. [DOI: 10.1136/bmj.326.7379.13] [PMID: ] - DOI - PMC - PubMed
Chaudhary 2013
    1. Chaudhary T, Walch E, Herold B, Metze B, Lejeune A, Burkhardt F, et al. Predictive and concurrent validity of standardized neurodevelopmental examinations by the Griffiths scales and Bayley Scales of Infant Development II. Klinische Padiatrie 2013;225(1):8-12. [DOI: 10.1055/s-0032-1331169] [PMID: ] - DOI - PubMed
Chen 2017
    1. Chen K, Lindrea K, Quah-Smith I, Daly M, Schindler T, Oei J. Magnetic noninvasive acupuncture for infant comfort (MAGNIFIC) – a single-blinded randomised controlled pilot trial. Acta Paediatrica 2017;106(11):1780-6. [DOI: 10.1111/apa.14002] [PMID: ] - DOI - PubMed
CIHI 2018
    1. Canadian Institute for Health Information. Opioid-related harms in Canada, 2018. cihi.ca/sites/default/files/document/opioid-related-harms-report-2018-en... (assessed prior to 1 December 2020).
Condon 1998
    1. Condon J, Corkindale CJ. The assessment of parent-to-infant attachment: development of a self-report questionnaire instrument. Journal of Reproductive and Infant Psychology 1998;16(1):57-76. [DOI: 10.1080/02646839808404558] - DOI
Corr 2017
    1. Corr T, Hollenbeak C. The economic burden of neonatal abstinence syndrome in the United States. Addiction 2017;112(9):1590-9. [DOI: 10.1111/add.13842] [PMID: ] - DOI - PubMed
Cox 1987
    1. Cox J, Holden J, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry 1987;150(6):782-6. [DOI: 10.1192/bjp.150.6.782] [PMID: ] - DOI - PubMed
Davies 2016
    1. Davies H, Gilbert R, Johnson K, Petersen I, Nazareth I, O'Donnell M, et al. Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia, and Ontario, Canada. Archives of Disease in Childhood. Fetal and Neonatal Edition 2016;101(1):F26-30. [DOI: 10.1136/archdischild-2015-308948] [PMID: ] - DOI - PubMed
Devlin 2020
    1. Devlin L, Breeze J, Terrin N, Gomez Pomar E, Bada H, Finnegan LP, et al. Association of a simplified Finnegan Neonatal Abstinence Scoring Tool with the need for pharmacologic treatment for neonatal abstinence syndrome. JAMA Network Open 2020;3(4):e202275. [DOI: ] [PMID: ] - PMC - PubMed
Faherty 2019
    1. Faherty L, Kranz A, Russell-Fritch J, Patrick S, Cantor J, Stein B. Association of punitive and reporting state policies related to substance use in pregnancy with rates of neonatal abstinence syndrome. JAMA Network Open 2019;2(11):e1914078. [DOI: ] [PMID: ] - PMC - PubMed
Fenton 2017
    1. Fenton TR, Chan HT, Madhu A, Griffin IJ, Hoyos A, Ziegler EE, et al. Preterm infant growth velocity calculations: a systematic review. Pediatrics 2017;139(3):e20162045. [DOI: 10.1542/peds.2016-2045] [PMID: ] - DOI - PubMed
Finnegan 1975
    1. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addictive Diseases 1975;2(1-2):141-58. [PMID: ] - PubMed
Gomez Pomar 2017
    1. Gomez Pomar E, Finnegan LP, Devlin L, Bada H, Concina VA, Ibonia KT, et al. Simplification of the Finnegan Neonatal Abstinence Scoring System: retrospective study of two institutions in the USA. BMJ Open 2017;7(9):e016176. [DOI: ] [PMID: ] - PMC - PubMed
Goyal 2020
    1. Goyal S, Saunders KC, Moore CS, Fillo K, Ko J, Manning S, et al. Identification of substance-exposed newborns and neonatal abstinence syndrome using ICD-10-CM – 15 Hospitals, Massachusetts, 2017. Morbidity and Mortality Weekly Report 2020;69(29):951-5. [DOI: 10.15585/mmwr.mm6929a2] [PMID: ] - DOI - PMC - PubMed
GRADEpro GDT [Computer program]
    1. GRADEpro GDT. Version accessed 2 February 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.
Graham 2010
    1. Graham A, Ablow J, Measelle J. Interparental relationship dynamics and cardiac vagal functioning in infancy. Infant Behavior & Development 2010;33(4):530-44. [DOI: 10.1016/j.infbeh.2010.07.005] [PMID: ] - DOI - PMC - PubMed
Gray 2000
    1. Gray L, Watt L Blass E. Skin-to-skin contact is analgesic in healthy newborns. Pediatrics 2000;105(1):e14. [DOI: 10.1542/peds.105.1.e14] [PMID: ] - DOI - PubMed
Gray 2002
    1. Gray L, Miller L, Philipp B, Blass E. Breastfeeding is analgesic in healthy newborns. Pediatrics 2002;109(4):590-3. [DOI: 10.1542/peds.109.4.590] [PMID: ] - DOI - PubMed
Green 1981
    1. Green M, Suffet F. The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. American Journal of Drug and Alcohol Abuse 1981;8(2):203-13. [DOI: 10.3109/00952998108999125] [PMID: ] - DOI - PubMed
Grossman 2018
    1. Grossman M, Lipshaw M, Osborn R, Berkwitt A. A novel approach to assessing infants with neonatal abstinence syndrome. Hospital Pediatrics 2018;8(1):1-6. [DOI: 10.1542/hpeds.2017-0128] [PMID: ] - DOI - PubMed
Hall 2015
    1. Hall E, Wexelblatt S, Crowley M, Grow J, Jasin L, Klebanoff M, et al, OCHNAS Consortium. Implementation of a neonatal abstinence syndrome weaning protocol: a multicenter cohort study. Pediatrics 2015;136(4):e803. [DOI: 10.1542/peds.2015-1141] [PMID: ] - DOI - PMC - PubMed
HCUP 2019
    1. Healthcare Cost and Utilization Project. HCUP Fast Stats, 2019. hcup-us.ahrq.gov/news/announcements/faststats092019update.jsp (accessed prior to 1 December 2020).
Higgins 2011
    1. Higgins JP, Altman DG, Sterne JA: on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2019
    1. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook. - PMC - PubMed
Hudak 2012
    1. Hudak M, Tan R, Committee on Drugs, Committee on Fetus and Newborn, American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012;129(2):e540-60. [DOI: 10.1542/peds.2011-3212] [PMID: ] - DOI - PubMed
Jansson 2009
    1. Academy of Breastfeeding Medicine Protocol Committee, Jansson LM. ABM clinical protocol #21: guidelines for breastfeeding and the drug-dependent woman. Breastfeeding Medicine 2009;4(4):225-8. [DOI: 10.1089/bfm.2009.9987] [PMID: ] - DOI - PMC - PubMed
Johnston 2017
    1. Johnston C, Campbell-Yeo M, Disher T, Benoit B, Fernandes A, Streiner D, et al. Skin-to-skin care for procedural pain in neonates. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No: CD008435. [DOI: 10.1002/14651858.CD008435.pub3] - DOI - PMC - PubMed
Jones 2010
    1. Jones HE, Kaltenback K, Heil SH, Stine S, Coyle M, Arria A, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine 2010;363(24):2320-31. [DOI: 10.1056/NEJMoa1005359] [PMID: ] - DOI - PMC - PubMed
Jones 2016a
    1. Jones HE, Seashore C, Johnson E, Horton E, O'Grady KE, Andringa K. Measurement of neonatal abstinence syndrome: evaluation of short forms. Journal of Opioid Management 2016;12(1):19-23. [DOI: 10.5055/jom.2016.0308] [PMID: ] - DOI - PubMed
Jones 2016b
    1. Jones H, Seashore C, Johnson E, Horton E, O'Grady K, Andringa K, et al. Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale. American Journal on Addictions 2016;25(5):370-3. [DOI: 10.1111/ajad.12388] [PMID: ] - DOI - PubMed
Juneau 2015
    1. Juneau A, Aita M, Heon M. Review and critical analysis of massage studies for term and preterm infants. Neonatal Network 2015;34(3):165-77. [DOI: 10.1891/0730-0832.34.3.165] [PMID: ] - DOI - PubMed
Kaplan 2008
    1. Kaplan L, Evans L, Monk C. Effects of mothers' prenatal psychiatric status and postnatal caregiving on infant biobehavioral regulation: can prenatal programming be modified? Early Human Development 2008;84(4):249-56. [DOI: 10.1016/j.earlhumdev.2007.06.004] [PMID: ] - DOI - PMC - PubMed
Kelly 2020
    1. Kelly L, Shan F, MacVicar S, Czaplinkski E, Moulsdale W, Simpson S, et al. A core outcome set for neonatal opioid withdrawal syndrome. Pediatrics 2020;146(1):e20200018. [DOI: ] [PMID: ] - PubMed
Ko 2016
    1. Ko JY, Patrick SW, Tong VT, Patel R, Lind JN, Barfield WD. Incidence of neonatal abstinence syndrome – 28 states, 1999–2013. Morbidity and Mortality Weekly Report 2016;65(31):799-802. [DOI: 10.15585/mmwr.mm6531a2] [PMID: ] - DOI - PubMed
Kocherlakota 2020
    1. Kocherlakota P, Qian E, Patel VC, Mandru C, Vilar RE, Alpan G, et al. A new scoring system for the assessment of neonatal abstinence syndrome. American Journal of Perinatology 2020;37(3):333-40. [DOI: ] [PMID: ] - PubMed
Krans 2019
    1. Krans EE, Campopiano M, Cleveland LM, Goodman D, Kilday D, Kendig S, et al. National partnership for maternal safety: consensus bundle on obstetric care for women with opioid use disorder. Obstetrics and Gynecology 2019;134(2):365-75. [DOI: 10.1097/AOG.0000000000003381] [PMID: ] - DOI - PubMed
Kroenke 2001
    1. Kroenke K, Spitzer R, Williams J. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine 2001;16(9):606-13. [DOI: 10.1046/j.1525-1497.2001.016009606.x] [PMID: ] - DOI - PMC - PubMed
Larson 2019
    1. Larson J, Graham D, Singer L, Beckwith A, Terplan M, Davis J, et al. Cognitive and behavioral impact on children exposed to opioids during pregnancy. Pediatrics 2019;144(2):e20190514. [DOI: ] [PMID: 31320466 ] - PMC - PubMed
Lee 2020
    1. Lee S, Bora S, Austin N, Westerman A, Hernderson J. Neurodevelopmental outcomes of children born to opioid-dependent mothers: a systematic review and meta-analysis. Academic Pediatrics 2020;20(3):308-18. [DOI: ] [PMID: ] - PubMed
Lemon 2018
    1. Lemon L, Naimi A, Caritis S, Platt R, Venkataramanan R, Bodnar L. The role of preterm birth in the association between opioid maintenance therapy and neonatal abstinence syndrome. Paediatric and Perinatal Epidemiology 2018;32(2):213-22. [DOI: 10.1111/ppe.12443] [PMID: ] - DOI - PMC - PubMed
Li 2009
    1. Li MD, Burmeister M. New insights into the genetics of addiction. Nature Reviews. Genetics 2009;10(4):225-31. [DOI: 10.1038/nrg2536] [PMID: ] - DOI - PMC - PubMed
Liaw 2012
    1. Liaw J, Yang L, Wang K, Chen C, Chang Y, Yin T. Non-nutritive sucking and facilitated tucking relieve preterm infant pain during heel-stick procedures: a prospective, randomised controlled crossover trial. International Journal of Nursing Studies 2012;49(3):300-9. [DOI: 10.1016/j.ijnurstu.2011.09.017] [PMID: ] - DOI - PubMed
Lipsitz 1975
    1. Lipsitz PJ. A proposed narcotic withdrawal score for use with newborn infants: a pragmatic evaluation of its efficacy. Clinical Pediatrics 1975;14(6):592-4. [DOI: 10.1177/000992287501400613] [PMID: ] - DOI - PubMed
Lisonkova 2019
    1. Lisonkova S, Richter L, Ting J, Muraca G, Mehrabadi A, Mitchell-Foster S, et al. Neonatal abstinence syndrome and associated neonatal and maternal mortality and morbidity. Pediatrics 2019;144(2):e20183664. [DOI: ] [PMID: ] - PubMed
MacMillan 2018
    1. MacMillan KD, Rendon CP, Verma K, Riblet N, Washer DB, Volpe Holmes A. Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis. JAMA Pediatrics 2018;172(4):345-51. [DOI: ] - PMC - PubMed
MacVicar 2019
    1. MacVicar S, Kelly LE. Systematic mixed-study review of nonpharmacological management of neonatal abstinence syndrome. Birth 2019;46(3):428-38. [DOI: 10.1111/birt.12427] - DOI - PubMed
Maguire 2013
    1. Maguire D, Cline GJ, Parnell L, Tai C-Y. Validation of the Finnegan neonatal abstinence syndrome tool – short form. Advances in Neonatal Care 2013;13(6):430-7. [DOI: 10.1097/ANC.0000000000000033] [PMID: ] - DOI - PubMed
Mangat 2019
    1. Mangat AK, Schmolzer GM, Kraft WK. Pharmacological and non-pharmacological treatments for the neonatal abstinence syndrome (NAS). Seminars in Fetal and Neonatal Medicine 2019;24(2):133-41. [DOI: ] [PMID: ] - PMC - PubMed
McQueen 2019
    1. McQueen K, Taylor C, Murphy-Oikonen J. Systematic review of newborn feeding method and outcomes related to neonatal abstinence syndrome. Journal of Obstetric, Gynecologic, and Neonatal Nursing 2019;48(4):398-407. [DOI: 10.1016/j.jogn.2019.03.004] - DOI - PubMed
Mehta 2013
    1. Mehta A, Forbes K, Kuppala V. Neonatal abstinence syndrome management from prenatal counseling to postdischarge follow-up care: results of a national survey. Hospital Pediatrics 2013;3(4):317-23. [DOI: 10.1542/hpeds.2012-0079] [PMID: ] - DOI - PubMed
Milliren 2018
    1. Milliren CE, Gupta M, Graham DA, Melvin P, Jorina M, Ozonoff A. Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use, and costs across pediatric hospitals in the United States, 2013 to 2016. Hospital Pediatrics 2018;8(1):15-20. [DOI: 10.1542/hpeds.2017-0077] [PMID: ] - DOI - PubMed
Moe‐Byrne 2018
    1. Moe-Byrne T, Brown J, McGuire W. Naloxone for opioid-exposed newborn infants. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No: CD003483. [DOI: 10.1002/14651858.CD003483.pub3] - DOI - PMC - PubMed
Moher 2009
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology 2009;62(10):1006-12. [DOI: ] [PMID: ] - PubMed
Moon 2016
    1. Moon RY, Task Force on Sudden Infant Death Syndrome. SIDS and other sleep-related infant deaths: evidence base for 2016 updated recommendations for a safe infant sleeping environment. Pediatrics 2016;138(5):e20162940. [DOI: 10.1542/peds.2016-2940] - DOI - PubMed
Muller 1994
    1. Muller ME. A questionnaire to measure mother-to-infant attachment. Journal of Nursing Measurement 1994;2(2):129-41. [PMID: ] - PubMed
Newman 2015
    1. Newman A, Davies GA, Dow K, Holmes B, Macdonald J, McKnight S, et al. Rooming-in care for infants of opioid-dependent mothers: implementation and evaluation at a tertiary care hospital. Canadian Family Physician Medecin de Famille Canadien 2015;61(12):555-61. [PMID: ] - PMC - PubMed
O'Donnell 2009
    1. O'Donnell M, Nassar N, Leonard H, Hagan R, Mathews R, Patterson Y, et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics 2009;123(4):e614-21. [DOI: ] [PMID: ] - PubMed
O'Grady 2009
    1. O'Grady MJ, Hopewell J, White MJ. Management of neonatal abstinence syndrome: a national survey and review of practice. Archives of Disease in Childhood. Fetal and Neonatal Edition 2009;94(4):F249-52. [DOI: 10.1136/adc.2008.152769] [PMID: ] - DOI - PubMed
Oostlander 2019
    1. Oostlander SA, Falla JA, Dow K, Fucile S. Occupational therapy management strategies for infants with neonatal abstinence syndrome: scoping review. Occupational Therapy in Health Care 2019;33(2):197-226. [DOI: 10.1080/07380577.2019.1594485] - DOI - PubMed
Osborn 2010a
    1. Osborn D, Jeffery H, Cole M. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No: CD002059. [DOI: 10.1002/14651858.CD002059.pub3] - DOI - PubMed
Osborn 2010b
    1. Osborn D, Jeffery H, Cole M. Sedatives for opiate withdrawal in newborn infants. Cochrane Database of Systematic Reviews 2010, Issue 10. Art. No: CD002053. [DOI: 10.1002/14651858.CD002053.pub3] - DOI - PubMed
Palisano 1997
    1. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Developmental Medicine and Child Neurology 1997;39(4):214-23. [DOI: 10.1111/j.1469-8749.1997.tb07414.x] [PMID: ] - DOI - PubMed
Paltrow 2013
    1. Paltrow LM, Flavin J. Arrests of and forced interventions on pregnant women in the United States, 1973–2005: implications for women's legal status and public health. Journal of Health Politics, Policy and Law 2013;38(2):299-343. [DOI: 10.1215/03616878-1966324] [PMID: ] - DOI - PubMed
Pandita 2018
    1. Pandita A, Panghal A, Gupta G, Verma A, Pillai A, Singh A, et al. Is kangaroo mother care effective in alleviating vaccination associated pain in early infantile period? A RCT. Early Human Development 2018;127:69-73. [DOI: 10.1016/j.earlhumdev.2018.10.001] [PMID: ] - DOI - PubMed
Patrick 2012
    1. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA 2012;307(18):1934-40. [DOI: 10.1001/jama.2012.3951] [PMID: ] - DOI - PubMed
Patrick 2015a
    1. Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009–2012. Journal of Perinatology 2015;35(8):650-5. [DOI: 10.1038/jp.2015.36] [PMID: ] - DOI - PMC - PubMed
Patrick 2015b
    1. Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, et al. Prescription opioid epidemic and infant outcomes. Pediatrics 2015;135(5):842-50. [DOI: 10.1542/peds.2014-3299] [PMID: ] - DOI - PMC - PubMed
Patrick 2019
    1. Patrick SW, Frank RG, McNeer E, Stein BD. Improving the child welfare system to respond to the needs of substance-exposed infants. Hospital Pediatrics 2019;9(8):651-4. [DOI: ] [PMID: ] - PMC - PubMed
Pinelli 2002
    1. Pinelli J, Symington A, Ciliska D. Nonnutritive sucking in high-risk infants: benign intervention or legitimate therapy? Journal of Obstetric, Gynecologic, and Neonatal Nursing 2002;31(5):582-91. [DOI: 10.1111/j.1552-6909.2002.tb00084.x] [PMID: ] - DOI - PubMed
Raith 2015
    1. Raith W, Schmölzer GM, Resch B, Reiterer F, Avian A, Koestenberger M, et al. Laser acupuncture for neonatal abstinence syndrome: a randomized controlled trial. Pediatrics 2015;136(5):876-84. [DOI: 10.1542/peds.2015-0676] - DOI - PubMed
Review Manager 2020 [Computer program]
    1. Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, Cochrane, 2020.
Ryan 2019
    1. Ryan G, Dooley J, Gerber Finn L, Kelly L. Nonpharmacological management of neonatal abstinence syndrome: a review of the literature. Journal of Maternal-fetal & Neonatal Medicine 2019;32(10):1735-40. [DOI: 10.1080/14767058.2017.1414180] - DOI - PubMed
Sarkar 2006
    1. Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. Journal of Perinatology 2006;26(1):15-7. [DOI: 10.1038/sj.jp.7211427] [PMID: ] - DOI - PubMed
Schmidt 2007
    1. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al, Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. New England Journal of Medicine 2007;357(19):1893-902. [DOI: 10.1056/NEJMoa073679] [PMID: ] - DOI - PubMed
Schünemann 2013
    1. Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
Shah 2012
    1. Shah PS, Herbozo C, Aliwalas LL, Shah VS. Breastfeeding or breast milk for procedural pain in neonates. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No: CD004950. [DOI: 10.1002/14651858.CD004950.pub3] - DOI - PMC - PubMed
Shan 2020
    1. Shan F, MacVicar S, Allegaert K, Offringa M, Jansson LM, Simpson S, et al. Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review. Trials 2020;21:262. [DOI: 10.1186/s13063-020-4183-9] - DOI - PMC - PubMed
Smith 2018
    1. Smith JG, Rogowski JA, Schoenauer KM, Lake ET. Infants in drug withdrawal: a national description of nurse workload, infant acuity, and parental needs. Journal of Perinatal & Neonatal Nursing 2018;32(1):72-9. [DOI: 10.1097/JPN.0000000000000309] [ 29373422] - DOI - PMC - PubMed
Snowden 2019
    1. Snowden JN, Akshatha A, Annett RD, Crawford MM, Das A, Devlin LA, et al. The ACT NOW clinical practice survey: gaps in the care of infants with neonatal opioid withdrawal syndrome. Hospital Pediatrics 2019;9(8):585-92. [DOI: ] [PMID: ] - PMC - PubMed
Sterne 2016
    1. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;12(355):i4919. [DOI: 10.1136/bmj.i4919] [PMID: ] - DOI - PMC - PubMed
Stine 2009
    1. Stine SM, Heil SH, Kaltenbach K, Martin PR, Coyle MG, Fischer G, et al. Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study. American Journal of Drug and Alcohol Abuse 2009;35(6):429-33. [DOI: 10.3109/00952990903374080] - DOI - PMC - PubMed
Taylor 2005
    1. Taylor A, Atkins R, Kumar R, Adams D, Glover V. A new mother-to-infant bonding scale: links with early maternal mood. Archives of Women's Mental Health 2005;8(1):45-51. [DOI: 10.1007/s00737-005-0074-z] [PMID: ] - DOI - PubMed
Tolia 2015
    1. Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. New England Journal of Medicine 2015;372(22):2118-26. [DOI: 10.1056/NEJMsa1500439] [PMID: ] - DOI - PubMed
Uebel 2015
    1. Uebel H, Wright IM, Burns L, Hilder L, Bajuk B, Breen C, et al. Reasons for rehospitalization in children who had neonatal abstinence syndrome. Pediatrics 2015;136(4):e811-20. [DOI: ] [PMID: ] - PubMed
Uebel 2016
    1. Uebel H, Wright IM, Burns L, Hilder L, Bajuk B, Breen C, et al. Epidemiological evidence for a decreasing incidence of neonatal abstinence syndrome, 2000–11. Paediatric and Perinatal Epidemiology 2016;30(3):267-73. [DOI: 10.1111/ppe.12282] [PMID: ] - DOI - PubMed
Velez 2009
    1. Velez M, Jansson LM. The opioid dependent mother and newborn dyad: non-pharmacologic care. Journal of Addiction Medicine 2008;2(3):113-20. [DOI: 10.1097/ADM.0b013e31817e6105] [PMID: ] - DOI - PMC - PubMed
Wachman 2018a
    1. Wachman EM, Warden AH, Thomas Z, Thomas-Lewis JA, Shrestha H, Nikita FN, et al. Impact of psychiatric medication co-exposure on neonatal abstinence syndrome severity. Drug and Alcohol Dependence 2018;192:45-50. [DOI: ] [PMID: ] - PubMed
Wachman 2018b
    1. Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, et al. Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome. Journal of Perinatology 2018;38(8):1114-22. [DOI: 10.1038/s41372-018-0109-8] [PMID: ] - DOI - PubMed
Whalen 2019
    1. Whalen BL, Holmes AV, Blythe S. Models of care for neonatal abstinence syndrome: what works? Seminars in Fetal & Neonatal Medicine 2019;24(2):121-32. [DOI: 10.1016/j.siny.2019.01.004] - DOI - PubMed
Whooley 1997
    1. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. Journal of General Internal Medicine 1997;12(7):439-45. [DOI: 10.1046/j.1525-1497.1997.00076.x] [PMID: ] - DOI - PMC - PubMed
Winkelman 2018
    1. Winkelman T, Villapiano N, Kozhimannil K, Davis M, Patrick S. Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004–2014. Pediatrics 2018;141(4):e20173520. [DOI: 10.1542/peds.2017-3520] [PMID: ] - DOI - PMC - PubMed
Yeoh 2019
    1. Yeoh SL, Eastwood J, Wright IM, Morton R, Melhuish E, Ward M, et al. Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis. JAMA Network Open 2019;2(7):e197025. [DOI: ] [PMID: ] - PMC - PubMed
Zahorodny 1998
    1. Zahorodny W, Rom C, Whitney W, Giddens S, Samuel M, Maichuk G, et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. Journal of Developmental and Behavioral Pediatrics 1998;19(2):89-93. [DOI: ] [PMID: ] - PubMed
Zhang 2018
    1. Zhang S, Su F, Li J, Chen W. The analgesic effects of maternal milk odor on newborns: a meta-analysis. Breastfeeding Medicine 2018;13(5):327-34. [DOI: 10.1089/bfm.2017.0226] [PMID: ] - DOI - PubMed

References to other published versions of this review

Pahl 2018
    1. Pahl A, Young L, Buus‐Frank ME, Marcellus L, Soll R. Non-pharmacological care for opioid withdrawal in newborns. Cochrane Database of Systematic Reviews 2018, Issue 12. Art. No: CD013217. [DOI: 10.1002/14651858.CD013217] - DOI - PMC - PubMed

Publication types

Associated data

LinkOut - more resources